• Kyung Hee Han, In Cheol Hwang, Sung Kim, Jae-Moon Bae, Young-Woo Kim, Keun Won Ryu, Jun Ho Lee, Jae-Hyung Noh, Tae-Sung Sohn, Dong Wook Shin, and Young Ho Yun.
• Division of Cancer Control and Hospital, National Cancer Center, Goyang, Korea.
• J Pain Symptom Manage. 2013 Oct 1;46(4):511-22.

ContextDepression in cancer survivors affects the rest of their lives in many ways.ObjectivesTo estimate the prevalence of depression and identify associated factors in disease-free stomach cancer survivors.MethodsWe enrolled 391 stomach cancer survivors who had been disease-free for at least one year after surgery from the cancer registries of two hospitals in Korea. Stomach cancer survivors were mailed a survey that included the Beck Depression Inventory, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30, and the associated stomach module, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Stomach Cancer Module 22.ResultsForty-four percent of survivors suffered from depression, and more women (49%) than men (42%) had high depression scores (Beck Depression Inventory >13). In multiple logistic regression analysis, lower income (odds ratio [OR] 2.49; 95% CI 1.64-3.78), problems with care before treatment (OR 1.92; 95% CI 1.23-2.98), body image change (OR 2.23; 95% CI 1.41-3.53), and symptoms of fatigue (OR 3.11; 95% CI 1.49-6.52), dyspnea (OR 2.57; 95% CI 1.48-4.45), or insomnia (OR 4.51; 95% CI 1.88-10.83) were associated with depression.ConclusionThe prevalence of depression was high in stomach cancer survivors even after the completion of treatment, especially among those with problems amenable to treatment, and we identified the associated factors. We suggest that stomach cancer survivors should be screened for depression after the end of treatment.Copyright © 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

32 keywords...

hide…